What is PhenoTips?
Founded in 2014, PhenoTips operates at the intersection of computer science and medical genetics. The company provides a sophisticated software suite designed to address the challenges of deep clinical phenotyping, a critical component in modern diagnostic workflows. By enabling clinicians to capture structured data and visualize complex family histories through pedigree drawing, PhenoTips empowers medical professionals to make more informed decisions regarding patient care and research. Its market position is defined by its adoption among top-tier research institutions and hospitals globally, establishing the platform as a standard-bearer for data-driven genetic investigation.
How much funding has PhenoTips raised?
PhenoTips has raised a total of $3.9M across 1 funding round:
Seed
$3.9M
Seed (2025): $3.9M with participation from GreenSky Capital, Yorkville Equity Partners, Toronto Innovation Acceleration Partners, and Thin Air Labs
Key Investors in PhenoTips
GreenSky Capital
Green Sky Ventures is an investment firm that focuses on early stage Canadian B2B start-ups led by exceptional entrepreneurs. They emphasize thorough diligence and are known for writing larger checks to fund their portfolio companies.
Yorkville Equity Partners
Yorkville Partners is a Private Equity Fund that specializes in investing in North American software technologies, technology, and e-commerce consumer goods businesses. The firm is managed by a team of experienced entrepreneurial advisors who focus on long-term growth.
Toronto Innovation Acceleration Partners
TIAP specializes in the venture building of early-stage health science technologies emerging from academic members. The company transforms scientific innovations into business ventures, providing expert financial and scientific advice to de-risk ideas.
What's next for PhenoTips?
With this major strategic investment, PhenoTips is poised to expand its operational capacity and enhance its software ecosystem. The company is expected to leverage these resources to deepen its integration with electronic health records and broaden its reach into new international markets. By focusing on the intersection of clinical utility and research scalability, PhenoTips aims to solve the persistent challenges in medical genetics, ultimately driving better patient outcomes. The strategic focus will likely shift toward optimizing its enterprise-grade infrastructure to support larger institutional deployments, ensuring that its technology remains at the forefront of the rapidly evolving precision medicine landscape.
See full PhenoTips company page
